Privi Speciality Chemicals Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Privi Speciality Chemicals's earnings have been declining at an average annual rate of -21.4%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 4.1% per year. Privi Speciality Chemicals's return on equity is 13.6%, and it has net margins of 7.2%.
Belangrijke informatie
-21.4%
Groei van de winst
-21.8%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 17.7% |
Inkomstengroei | 4.1% |
Rendement op eigen vermogen | 13.6% |
Nettomarge | 7.2% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Privi Speciality Chemicals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 18,849 | 1,358 | 778 | 0 |
30 Jun 24 | 18,075 | 1,217 | 750 | 0 |
31 Mar 24 | 17,522 | 949 | 727 | 0 |
31 Dec 23 | 16,666 | 502 | 749 | 0 |
30 Sep 23 | 16,826 | 271 | 741 | 0 |
30 Jun 23 | 16,277 | 45 | 765 | 0 |
31 Mar 23 | 16,078 | 222 | 797 | 0 |
31 Dec 22 | 15,860 | 658 | 800 | 0 |
30 Sep 22 | 15,607 | 851 | 805 | 0 |
30 Jun 22 | 14,602 | 905 | 787 | 0 |
31 Mar 22 | 14,037 | 974 | 767 | 0 |
31 Dec 21 | 13,800 | 1,273 | 733 | 0 |
30 Sep 21 | 13,125 | 1,212 | 705 | 0 |
30 Jun 21 | 13,196 | 1,249 | 717 | 0 |
31 Mar 21 | 12,766 | 1,169 | 700 | 0 |
31 Dec 20 | 15,391 | 1,224 | 874 | 0 |
30 Sep 20 | 15,218 | 1,350 | 867 | 0 |
30 Jun 20 | 15,027 | 1,607 | 821 | 0 |
31 Mar 20 | 13,241 | 1,460 | 652 | 0 |
31 Dec 19 | 16,737 | 1,819 | 824 | 0 |
30 Sep 19 | 16,618 | 2,135 | 802 | 0 |
30 Jun 19 | 15,543 | 1,655 | 758 | 0 |
31 Mar 19 | 13,410 | 942 | 717 | 0 |
31 Dec 18 | 12,149 | 682 | 657 | 0 |
30 Sep 18 | 11,089 | 86 | 636 | 0 |
30 Jun 18 | 10,493 | 103 | 608 | 0 |
31 Mar 18 | 10,243 | 534 | 579 | 0 |
31 Dec 17 | 9,328 | 293 | 616 | 0 |
30 Sep 17 | 8,319 | 262 | 579 | 0 |
30 Jun 17 | 7,659 | 257 | 515 | 0 |
31 Mar 17 | 5,973 | 271 | 359 | 0 |
31 Dec 16 | 1,727 | 128 | 99 | 0 |
30 Sep 16 | 1,686 | 138 | 93 | 0 |
30 Jun 16 | 1,590 | 141 | 83 | 0 |
31 Mar 16 | 1,517 | 106 | 78 | 0 |
31 Dec 15 | 1,468 | 86 | 131 | 0 |
30 Sep 15 | 1,452 | 79 | 128 | 0 |
30 Jun 15 | 1,458 | 91 | 126 | 0 |
31 Mar 15 | 1,506 | 137 | 75 | 0 |
31 Dec 14 | 1,583 | 171 | 122 | 0 |
30 Sep 14 | 1,605 | 196 | 117 | 0 |
30 Jun 14 | 1,639 | 211 | 114 | 0 |
31 Mar 14 | 1,518 | 187 | 110 | 0 |
31 Dec 13 | 1,366 | 134 | 78 | 0 |
Kwaliteitswinsten: 530117 has high quality earnings.
Groeiende winstmarge: 530117's current net profit margins (7.2%) are higher than last year (1.6%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 530117's earnings have declined by 21.4% per year over the past 5 years.
Versnelling van de groei: 530117's earnings growth over the past year (401.5%) exceeds its 5-year average (-21.4% per year).
Winst versus industrie: 530117 earnings growth over the past year (401.5%) exceeded the Chemicals industry 10.4%.
Rendement op eigen vermogen
Hoge ROE: 530117's Return on Equity (13.6%) is considered low.